Tolerability + symptom support tools (troubleshooting guide, food tolerance ladder, GI comfort plan, symptom log)
Novo Nordisk's patent for semaglutide is expected to expire in March 2026, after which all drug manufacturing companies can legally produce semaglutide to the public
So, while Ozempic may (STILL) not have received the FDA's seal of approval for weight loss in non-diabetic patients, its hidden talent paved the way for Wegovy to step into the spotlight and take on a leading role in weight management
Similarly, anything high in added sugar can sabotage GLP-1 newbies
Your needs depend on your body size, activity level, medical history, and goals
People taking Saxenda may want to switch to Wegovy because there are fewer injections needed (once weekly versus once daily), and Wegovy may be more effective at aiding weight loss